These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35657750)

  • 1. Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients.
    Shih AR; Hatipoglu D; Wilechansky R; Goiffon R; Deshpande V; Misdraji J; Chung RT
    Arch Pathol Lab Med; 2022 Oct; 146(10):1184-1193. PubMed ID: 35657750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Faruqui S; Okoli FC; Olsen SK; Feldman DM; Kalia HS; Park JS; Stanca CM; Figueroa Diaz V; Yuan S; Dagher NN; Sarkar SA; Theise ND; Kim S; Shanbhogue K; Jacobson IM
    Am J Gastroenterol; 2021 Jul; 116(7):1414-1425. PubMed ID: 33993134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.
    Bütikofer S; Lenggenhager D; Wendel Garcia PD; Maggio EM; Haberecker M; Reiner CS; Brüllmann G; Buehler PK; Gubler C; Müllhaupt B; Jüngst C; Morell B
    Liver Int; 2021 Oct; 41(10):2404-2417. PubMed ID: 34018314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation.
    Cesar Machado MC; Filho RK; El Bacha IAH; de Oliveira IS; Ribeiro CMF; de Souza HP; Parise ER
    Am J Case Rep; 2022 Aug; 23():e936250. PubMed ID: 35978523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.
    Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M
    Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection.
    Edwards K; Allison M; Ghuman S
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33168538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary sclerosing cholangitis in patients with drug-induced liver injury.
    Gudnason HO; Björnsson HK; Gardarsdottir M; Thorisson HM; Olafsson S; Bergmann OM; Björnsson ES
    Dig Liver Dis; 2015 Jun; 47(6):502-7. PubMed ID: 25840876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
    Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis.
    Fejfar T; Vaňásek T; Hůlek P
    Vnitr Lek; 2020; 66(5):287-300. PubMed ID: 32942866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 related biliary injury: A review of recent literature.
    Yadlapati S; Jarrett SA; Baik D; Chaaya A
    World J Gastroenterol; 2023 Apr; 29(14):2127-2133. PubMed ID: 37122603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.
    Gelbmann CM; Rümmele P; Wimmer M; Hofstädter F; Göhlmann B; Endlicher E; Kullmann F; Langgartner J; Schölmerich J
    Am J Gastroenterol; 2007 Jun; 102(6):1221-9. PubMed ID: 17531010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked eosinophilia as the first manifestation of sclerosing cholangitis.
    Horiuchi K; Kakizaki S; Kosone T; Ichikawa T; Sato K; Takagi H; Mori M; Sakurai S; Fukusato T
    Intern Med; 2009; 48(16):1377-82. PubMed ID: 19687582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-associated secondary sclerosing cholangitis - A case series of 4 patients.
    Ferreira FB; Mourato M; Bragança S; Paulo JB; Sismeiro R; Pereira A; Mónica AN; Lourenço LC; Cardoso M
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102048. PubMed ID: 36347499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary sclerosing cholangitis.
    Ruemmele P; Hofstaedter F; Gelbmann CM
    Nat Rev Gastroenterol Hepatol; 2009 May; 6(5):287-95. PubMed ID: 19404269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
    Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
    J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endoscopic treatment in patients with secondary sclerosing cholangitis.
    Zhang CC; Sauer P; Rupp C
    J Gastroenterol Hepatol; 2022 Oct; 37(10):2011-2018. PubMed ID: 35933581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature.
    Bauer U; Pavlova D; Abbassi R; Lahmer T; Geisler F; Schmid RM; Ehmer U
    Clin J Gastroenterol; 2022 Dec; 15(6):1124-1129. PubMed ID: 35953614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
    Linder S; Söderlund C
    Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastrointestinal endoscopy in the diagnosis and treatment of biliary liver disease].
    Liang XY; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):690-695. PubMed ID: 36038336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.